Study Characteristics | N (%) | Post-Surgical Complicationsa OR (95Â % CI) | P-value | In-Hospital Mortalitya OR (95Â % CI) | P-value |
---|---|---|---|---|---|
Age | 104834 | 1.01 (1.01, 1.01) | <.0001 | 1.05 (1.05, 1.06) | <.0001 |
Sex | Â | Â | <.0001 | Â | <.0001 |
 Male | 52193 (49.8) | Ref |  | Ref |  |
 Female | 52510 (50.2) | 0.77 (0.73, 0.81) |  | 0.72 (0.65, 0.79) |  |
Race/Ethnicity | Â | Â | 0.0021 | Â | 0.0364 |
 White | 66339 (76.6) | Ref |  | Ref |  |
 Black | 9091 (10.5) | 1.07 (1.01, 1.13) |  | 1.18 (1.00, 1.39) |  |
 Hispanic | 5837 (6.7) | 0.93 (0.87, 0.99) |  | 1.01 (0.82, 1.24) |  |
 Other | 5356 (6.2) | 0.96 (0.90, 1.02) |  | 0.79 (0.63, 1.01) |  |
Residential Income | Â | Â | 0.0472 | Â | 0.0080 |
 Q4-Highest | 24504 (24.1) | Ref |  | Ref |  |
 Q3 | 25238 (24.9) | 1.05 (1.01, 1.10) |  | 1.19 (1.03, 1.36) |  |
 Q2 | 26492 (26.1) | 1.01 (0.96, 1.06) |  | 1.20 (1.04, 1.39) |  |
 Q1-Lowest | 25300 (24.9) | 0.99 (0.95, 1.04) |  | 1.30 (1.11, 1.51) |  |
Stage | Â | Â | <.0001 | Â | <.0001 |
 Non-Metastatic | 5397 (13.5) | Ref |  | Ref |  |
 Metastatic | 24142 (60.3) | 1.17 (1.13, 1. 21) |  | 1.80 (1.63, 1.99) |  |
Insurance Type | Â | Â | <.0001 | Â | <.0001 |
 Private | 34356 (33.6) | Ref |  | Ref |  |
 Medicare | 59102 (57.0) | 1.16 (1.11, 1.22) |  | 1.23 (1.05, 1.45) |  |
 Medicaid | 4976 (4.8) | 1.15 (1.07, 1.25) |  | 1.66 (1. 23, 2.22) |  |
 Other | 5216 (5.0) | 1.03 (0.95, 1.12) |  | 1.95 (1.49, 2.56) |  |
Residential Region | Â | Â | 0.0116 | Â | 0.6859 |
 Large metro | 52149 (56.2) | Ref |  | Ref |  |
 Small metro | 28372 (30.6) | 0.95 (0.91, 0.99) |  | 0.96 (0.86, 1.08) |  |
 Micropolitan | 12260 (13.2) | 1.01 (0.95, 1.06) |  | 0.95 (0.80, 1.08) |  |
Comorbidities | Â | Â | <.0001 | Â | <.0001 |
 0 | 72084 (69.6) | Ref |  | Ref |  |
 1 | 23234 (22.4) | 1.19 (1.14, 1.23) |  | 1.86 (1.67, 2.08) |  |
 ≥ 2 | 8332 (8.0) | 1.19 (1.13, 1.26) |  | 3.11 (2.73, 3.54) |  |